Tumor vascular biomarkers: New opportunities for cancer diagnostics

Cancer Biomarkers

Volumn 8, Issue 4-5, 2010, Pages 253-271

  Li, Chunsheng ^a   Sasaroli, Dimitra ^a   Chen, Xiang ^a   Hu, Jia ^a   Sandaltzopoulos, Raphael ^b   Omidi, Yadolah ^a   Coukos, George ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; BIOLOGICAL MARKER; CADHERIN; CD133 ANTIGEN; CD14 ANTIGEN; CD146 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; GELATINASE B; MICRORNA; TUMOR ANTIGEN; VASCULOTROPIN RECEPTOR; VON WILLEBRAND FACTOR;

ANGIOGENESIS; ARTICLE; BRAIN TUMOR; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER IMMUNOTHERAPY; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DOPPLER ECHOGRAPHY; DRUG EFFICACY; DRUG TARGETING; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; GLIOMA; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC CELL; HEMODYNAMIC PARAMETERS; HUMAN; LIVER CELL CARCINOMA; LIVER METASTASIS; LUNG CANCER; METASTASIS; MICROARRAY ANALYSIS; MICROVASCULATURE; MOLECULARLY TARGETED THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY CANCER; POLYMERASE CHAIN REACTION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEOMICS; SERIAL ANALYSIS OF GENE EXPRESSION; SOLID TUMOR; TUMOR; VASCULARIZATION;

ANGIOGRAPHY; ANIMALS; BLOOD VESSELS; ENDOTHELIAL CELLS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; TUMOR MARKERS, BIOLOGICAL;

EID: 81155125989     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-2011-0217     Document Type: Article

References (99)

1. C.H. Pui, L.L. Robison, A.T. Look, Acute lymphoblastic leukaemia, Lancet 371 (2008), 1030-1043. (Pubitemid 351389536)
2. R. Storb, Allogeneic hematopoietic stem cell transplantation- yesterday, today, and tomorrow, Exp Hematol 31 (2003), 1-10. (Pubitemid 36110525)
3. I. Hamad and S.M. Moghimi, Critical issues in site-specific targeting of solid tumours: the carrier, the tumour barriers and the bioavailable drug, Expert Opin Drug Deliv 5 (2008), 205-219. (Pubitemid 351308312)
4. J. Folkman, Angiogenesis in cancer, vascular, rheumatoid and other disease, Nat Med 1 (1995), 27-31.
5. R.J. Buckanovich, A. Facciabene, S. Kim, F. Benencia, D. Sasaroli, K. Balint, D. Katsaros, A. O'Brien-Jenkins, P.A. Gimotty and G. Coukos, Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy, Nat Med 14 (2008), 28-36.
6. M. Furuya, Y. Yonemitsu and I. Aoki, III. Angiogenesis: complexity of tumor vasculature and microenvironment, Curr Pharm Des 15 (2009), 1854-1867.
7. K. McLean and R.J. Buckanovich, Myeloid cells functioning in tumor vascularization as a novel therapeutic target, Transl Res 151 (2008), 59-67.
8. B. St Croix, C. Rago, V. Velculescu, G. Traverso, K.E. Romans, E. Montgomery, A. Lal, G.J. Riggins, C. Lengauer, B. Vogelstein and K.W. Kinzler, Genes expressed in human tumor endothelium, Science 289 (2000), 1197-1202. (Pubitemid 30650733)
9. R.A. Costa, R. Jorge, D. Calucci, L.A.Melo, Jr., J.A. Cardillo, I.U. Scott, Intravitreal bevacizumab (avastin) for central and hemicentral retinal vein occlusions: IBeVO study, Retina 27 (2007), 141-149.
10. S.B. Fox, D.G. Generali and A.L. Harris, Breast tumour angiogenesis, Breast Cancer Res 9 (2007) 216.
11. L. Pickering, S. Rudman, P.J. Ross and M.D. Leslie, Targeted therapy in colorectal carcinoma: more than a theory, Colorectal Dis 10 (2008), 209-218; discussion 218-221. (Pubitemid 351284670)
12. G.P. Adams and L.M. Weiner, Monoclonal antibody therapy of cancer, Nat Biotechnol 23 (2005), 1147-1157. (Pubitemid 41486396)
13. R.J. Buckanovich, D. Sasaroli, A. O'Brien-Jenkins, J. Botbyl, J.R. Conejo-Garcia, F. Benencia, L.A. Liotta, P.A. Gimotty and G. Coukos, Use of immuno-LCM to identify the in situ expression profile of cellular constituents of the tumor microenvironment, Cancer Biol Ther 5 (2006), 635-642. (Pubitemid 44024718)
14. R. Bhati, C. Patterson, C.A. Livasy, C. Fan, D. Ketelsen, Z. Hu, E. Reynolds, C. Tanner, D.T. Moore, F. Gabrielli, C.M. Perou and N. Klauber-DeMore, Molecular characterization of human breast tumor vascular cells, Am J Pathol 172 (2008), 1381-1390. (Pubitemid 351671550)
15. R.J. Buckanovich, D. Sasaroli, A. O'Brien-Jenkins, J. Botbyl, R. Hammond, D. Katsaros, R. Sandaltzopoulos, L.A. Liotta, P.A. Gimotty and G. Coukos, Tumor vascular proteins as biomarkers in ovarian cancer, J Clin Oncol 25 (2007), 852-861. (Pubitemid 350002886)
16. C. Lu, A.A. Kamat, Y.G. Lin,W.M.Merritt, C.N. Landen, T.J. Kim, W. Spannuth, T. Arumugam, L.Y. Han, N.B. Jennings, C. Logsdon, R.B. Jaffe, R.L. Coleman and A.K. Sood, Dual targeting of endothelial cells and pericytes in antivascular therapy for ovarian carcinoma, Clin Cancer Res 13 (2007), 4209-4217. (Pubitemid 47105985)
17. S.L. Madden, B.P. Cook, M. Nacht, W.D.Weber, M.R. Callahan, Y. Jiang, M.R. Dufault, X. Zhang, W. Zhang, J. Walter- Yohrling, C. Rouleau, V.R. Akmaev, C.J. Wang, X. Cao, T.B. St Martin, B.L. Roberts, B.A. Teicher, K.W. Klinger, R.V. Stan, B. Lucey, E.B. Carson-Walter, J. Laterra and K.A. Walter, Vascular gene expression in nonneoplastic and malignant brain, Am J Pathol 165 (2004), 601-608. (Pubitemid 38971389)
18. B.S. Parker, P. Argani, B.P. Cook, H. Liangfeng, S.D. Chartrand, M. Zhang, S. Saha, A. Bardelli, Y. Jiang, T.B. StMartin, M. Nacht, B.A. Teicher, K.W. Klinger, S. Sukumar and S.L. Madden, Alterations in vascular gene expression in invasive breast carcinoma, Cancer Res 64 (2004), 7857-7866. (Pubitemid 39446919)
19. S. Rafii and D. Lyden, A Few to Flip the Angiogenic Switch, Science 318 (2008), 163-164.
20. E.Y. Lin and J.W. Pollard, Tumor-Associated Macrophages Press the Angiogenic Switch in Breast Cancer, Cancer Res 67 (2007), 5064-5066. (Pubitemid 46997238)
21. D. Neri and R. Bicknell, Tumour Vascular Targeting, Nature Reviews Cancer 5 (2005), 436-446. (Pubitemid 40791486)
22. M. Furuya, Y.Yonemitsu and I. Aoki, III. Angiogenesis: Complexity of Tumor Vasculature and Microenvironment, Current Pharmaceutical Design 15 (2009), 1854-1867.
23. D.H. Ausprunk and J. Folkman,Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis, Microvasc Res 14 (1977), 53-65. (Pubitemid 8153798)
24. D. Lyden, K. Hattori, S. Dias, C. Costa, P. Blaikie, L. Butros, A. Chadburn, B. Heissig,W.Marks, L.Witte, Y.Wu, D. Hicklin, Z. Zhu, N.R. Hackett, R.G. Crystal, M.A. Moore, K.A. Hajjar, K. Manova, R. Benezra and S. Rafii, Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth, Nat Med 7 (2001), 1194-1201. (Pubitemid 33063774)
25. M. De Palma, M.A. Venneri, C. Roca and L. Naldini, Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells, Nat Med 9 (2003), 789-795. (Pubitemid 36749231)
26. J.R. Gothert, S.E. Gustin, J.A. van Eekelen, U. Schmidt, M.A. Hall, S.M. Jane, A.R. Green, B. Gottgens, D.J. Izon and C.G. Begley, Genetically tagging endothelial cells in vivo: bone marrow-derived cells do not contribute to tumor endothelium, Blood 104 (2004), 1769-1777. (Pubitemid 39202286)
27. G.O. Ahn and J.M. Brown, Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells, Cancer Cell 13 (2008), 193-205. (Pubitemid 351318369)
28. A. Eberhard, S. Kahlert, V. Goede, B. Hemmerlein, K.H. Plate and H.G. Augustin, Heterogeneity of Angiogenesis and Blood Vessel Maturation in Human Tumors: Implications for Antiangiogenic Tumor Therapies, Cancer Res 60 (2000), 1388-1393. (Pubitemid 30152012)
29. G.N. Naumov, L.A. Akslen and J. Folkman, Role of angiogenesis in human tumor dormancy: animal models of the angiogenic switch, Cell Cycle 5 (2006), 1779-1787. (Pubitemid 44435320)
30. W.C. Black and H.G.Welch, Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy, N Engl J Med 328 (1993), 1237-1243. (Pubitemid 23115703)
31. P.K. Goon, C.J. Boos, P.S. Stonelake and G.Y. Lip, Circulating endothelial cells in malignant disease, Future Oncol 1 (2005), 813-820.
32. P.K. Goon, C.J. Boos and G.Y. Lip, Circulating endothelial cells: markers of vascular dysfunction, Clin Lab 51 (2005), 531-538. (Pubitemid 41644193)
33. L.V. Beerepoot, N. Mehra, J.S. Vermaat, B.A. Zonnenberg, M.F. Gebbink and E.E. Voest, Increased levels of viable circulating endothelial cells are an indicator of progressive disease in cancer patients, Ann Oncol 15 (2004), 139-145. (Pubitemid 38139616)
34. P. Mancuso, A. Burlini, G. Pruneri, A. Goldhirsch, G. Martinelli and F. Bertolini, Resting and activated endothelial cells are increased in the peripheral blood of cancer patients, Blood 97 (2001), 3658-3661.
35. A. Alonci, A. Allegra, G. Bellomo, G. Penna, A. D'Angelo, E. Quartarone and C. Musolino, Evaluation of circulating endothelial cells, VEGF and VEGFR2 serum levels in patients with chronic myeloproliferative diseases, Hematol Oncol 26 (2008), 235-239.
36. J. Trelinski, A. Wierzbowska, A. Krawczynska, A. Sakowicz, T. Pietrucha, P. Smolewski, T. Robak and K. Chojnowski, Plasma levels of angiogenic factors and circulating endothelial cells in essential thrombocythemia: correlation with cytoreductive therapy and JAK2-V617F mutational status, Leuk.Lymphoma, (2010).
37. T. Asahara, T. Murohara, A. Sullivan, M. Silver, R. van der Zee, T. Li, B. Witzenbichler, G. Schatteman and J.M. Isner, Isolation of putative progenitor endothelial cells for angiogenesis, Science 275 (1997), 964-967. (Pubitemid 27087709)
38. B. Dome, J. Timar, A. Ladanyi, S. Paku, F. Renyi-Vamos, W. Klepetko, G. Lang, P. Dome, K. Bogos and J. Tovari, Circulating endothelial cells, bone marrow-derived endothelial progenitor cells and proangiogenic hematopoietic cells in cancer: From biology to therapy, Crit Rev Oncol Hematol 69 (2009), 108-124.
39. P.K. Goon, G.Y. Lip, C.J. Boos, P.S. Stonelake andA.D.Blann, Circulating endothelial cells, endothelial progenitor cells, and endothelial microparticles in cancer, Neoplasia 8 (2006), 79-88.
40. Z. Mallat, H. Benamer, B. Hugel, J. Benessiano, P.G. Steg, J.M. Freyssinet and A. Tedgui, Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes, Circulation 101 (2000), 841-843. (Pubitemid 30117876)
41. Y. Wang, J. Tao, Z. Yang, C. Tu, M.G. Xu, J.M. Wang and Y.J. Huang, Tumor necrosis factor-alpha induces release of endothelial microparticles from human endothelial cells, Zhonghua Xin Xue Guan Bing Za Zhi 33 (2005), 1137-1140. (Pubitemid 43262234)
42. J.R. Conejo-Garcia, R.J. Buckanovich, F. Benencia, M.C. Courreges, S.C. Rubin, R.G. Carroll and G. Coukos, Vascular leukocytes contribute to tumor vascularization, Blood 105 (2005), 679-681. (Pubitemid 40070752)
43. G. Coukos, F. Benencia, R.J. Buckanovich and J.R. Conejo- Garcia, The role of dendritic cell precursors in tumour vasculogenesis, Br J Cancer 92 (2005), 1182-1187. (Pubitemid 40604389)
44. D.M. McDonald and P.L. Choyke, Imaging of angiogenesis: from microscope to clinic, Nature Med 9 (2003), 713-725. (Pubitemid 36749220)
45. M. Papetti and I.M. Herman, Mechanisms of normal and tumor-derived angiogenesis, Am J Physiol Cell Physiol 282 (2002), 947-970.
46. M. Allinen, R. Beroukhim, L. Cai, C. Brennan, J. Lahti- Domenici, H. Huang, D. Porter, M. Hu, L. Chin, A. Richardson, S. Schnitt, W.R. Sellers and K. Polyak, Molecular characterization of the tumor microenvironment in breast cancer, Cancer Cell 6 (2004), 17-32. (Pubitemid 38903159)
47. C. Gillis, L. Bengtsson, B. Wilman and A. Haegerstrand, Secretion of prostacyclin, tissue plasminogen activator and its inhibitor by cultured adult human endothelial cells grown on different matrices, Eur J Vasc Endovasc Surg 11 (1996), 127-133. (Pubitemid 26120463)
48. L. Liaw and S.M. Schwartz, Comparison of gene expression in bovine aortic endothelium in vivo versus in vitro. Differences in growth regulatory molecules, Arterioscler Thromb 13 (1993), 985-993. (Pubitemid 23195800)
49. J. Middleton, L. Americh, R. Gayon, D. Julien, M. Mansat, P. Mansat, P. Anract, A. Cantagrel, P. Cattan, J.M. Reimund, L. Aguilar, F. Amalric and J.P. Girard, A comparative study of endothelial cell markers expressed in chronically inflamed human tissues: MECA-79, Duffy antigen receptor for chemokines, vonWillebrand factor, CD31, CD34, CD105 and CD146, J Pathol 3 (2005), 260-268. (Pubitemid 40903190)
50. R.J. Buckanovich, D. Sasaroli, A. O'brien-Jenkins, J. Botbyl, J.R. Conejo-Garcia, F. Benencia, L.A. Liotta, P.A. Gimotty and G. Coukos, Use of immuno-LCM to identify the in situ expression profile of cellular constituents of the tumor microenvironment, Cancer Biol Ther 5 (2006), 635-642. (Pubitemid 44024718)
51. J.R. Conejo-Garcia, F. Benencia, M.C. Courreges, E. Kang, A. Mohamed-Hadley, R.J. Buckanovich, D.O. Holtz, A. Jenkins, H. Na, L. Zhang, D.S. Wagner, D. Katsaros, R. Caroll and G. Coukos, Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of Vegf-A, Nat Med 10 (2004), 950-958. (Pubitemid 39273736)
52. W.D. Patino, O.Y. Mian and P.M. Hwang, Serial analysis of gene expression: technical considerations and applications to cardiovascular biology, Circ Res 91 (2002), 565-569.
53. V.E. Velculescu, L. Zhang, B. Vogelstein and K.W. Kinzler, Serial analysis of gene expression, Science 270 (1995), 484-487.
54. M. Ishii, S. Hashimoto, S. Tsutsumi, Y.Wada, K. Matsushima, T. Kodama and H. Aburatani, Direct comparison of GeneChip and SAGE on the quantitative accuracy in transcript profiling analysis, Genomics 68 (2000), 136-143.
55. M. Ho, E.Yang, G. Matcuk, D. Deng, N. Sampas,A. Tsalenko, R. Tabibiazar, Y. Zhang, M. Chen, S. Talbi, Y.D. Ho, J.Wang, P.S. Tsao, A. Ben-Dor, Z. Yakhini, L. Bruhn and T. Quertermous, Identification of endothelial cell genes by combined database mining and microarray analysis, Physiol Genomics 13 (2003), 249-262. (Pubitemid 37129190)
56. C. Hidai, T. Zupancic, K. Penta, A.Mikhail, M. Kawana, E.E. Quertermous, Y. Aoka, M. Fukagawa, Y. Matsui, D. Platika, R. Auerbach, B.L. Hogan, R. Snodgrass and T. Quertermous, Cloning and characterization of developmental endothelial locus-1: an embryonic endothelial cell protein that binds the alphavbeta3 integrin receptor, Genes Dev 12 (1998), 21-33. (Pubitemid 28083655)
57. Y. Aoka, F.L. Johnson, K. Penta, K. Hirata Ki, C. Hidai, R. Schatzman, J.A. Varner and T. Quertermous, The embryonic angiogenic factor Del1 accelerates tumor growth by enhancing vascular formation, Microvasc Res 64 (2002), 148-161. (Pubitemid 34713241)
58. M.E. Gerritsen, R. Soriano, S. Yang, G. Ingle, C. Zlot, K. Toy, J. Winer, A. Draksharapu, F. Peale, T.D. Wu and P.M. Williams, In silico data filtering to identify new angiogenesis targets from a large in vitro gene profiling data set, Physiol Genomics 10 (2002), 13-20. (Pubitemid 135707425)
59. J. Kahn, F. Mehraban, G. Ingle, X. Xin, J.E. Bryant, G. Vehar, J. Schoenfeld, C.J. Grimaldi, F. Peale, A. Draksharapu, D.A. Lewin and M.E. Gerritsen, Gene expression profiling in an in vitro model of angiogenesis, Am J Pathol 156 (2000), 1887-1900. (Pubitemid 30641758)
60. B. Borgia, C. Roesli, T. Fugmann, C. Schliemann, M. Cesca, D. Neri and R. Giavazzi, A Proteomic Approach for the Identification of Vascular Markers of Liver Metastasis, Cancer Research 70 (2009), 309-318.
61. H. Hu, Y. Ran, Y. Zhang, Z. Zhou, S.J. Harris, L. Yu, L. Sun, J. Pan, J. Liu, J. Lou and Z. Yang, Antibody Library-based Tumor EndothelialCells Surface Proteomic Functional Screen Reveals Migration-stimulating Factor as an Anti-angiogenic Target, Molecular & Cellular Proteomics (2009), 816-826.
62. P.R. Srinivas, M. Verma, Y.M. Zhao and S. Srivastava, Proteomics for Cancer Biomarker Discovery, Clinical Chemistry 48 (2002), 1160-1169. (Pubitemid 34809820)
63. S.B. Scheurer, J.N. Rybak, C. Rosli, D. Neri and G. Elia, Modulation of gene expression by hypoxia in human umbilical cord vein endothelial cells: A transcriptomic and proteomic study, Proteomics 4 (2004), 1737-1760. (Pubitemid 38738330)
64. E. Durr, J. Yu, K.M. Krasinska, L.A. Carver, J.R. Yates, J.E. Testa, P. Oh and J.E. Schnitzer, Direct proteomic mapping of the lung microvascular endothelial cell surface in vivo and in cell culture, Nat Biotechnol 22 (2004), 985-992. (Pubitemid 39014475)
65. V. Strassberger, T. Fugmann, D. Neri and C. Roesli, Chemical proteomic and bioinformatic strategies for the identification and quantification of vascular antigens in cancer, J Proteomics 73 (2010), 1954-1973.
66. D.A. Mustafa, P.C. Burgers, L.J. Dekker, H. Charif, M.K. Titulaer, P.A. Smitt, T.M. Luider and J.M. Kros, Identification of glioma neovascularization- related proteins by using MALDI-FTMS and nano-LC fractionation to microdissected tumor vessels,Mol Cell Proteomics 6 (2007), 11.
67. P. Kumar, J.M.Wang and C. Bernabeu, CD105 and angiogenesis, J Pathol 178 (1996), 4.
68. C. Li, R.Gardy, B.K. Seon, S.E. Duff, S. Abdalla, A. Ranehan, S.T. O'Dwyer, N. Haboubi and S. Kumar, Both high intratumoral microvessel density determined using CD105 antibody and elevated plasma levels of CD105 in colorectal cancer patients correlate with poor prognosis, Br J Cancer 88 (2003), 8.
69. S.E. Duff, C. Li, J.M. Garland and S. Kumar, CD105 is important for angiogenesis: evidence and potential applications, FASEB J 17 (2003), 9.
70. R. Minhajat, D. Mori, F. Yamasaki, Y. Sugita, T. Satoh and O. Tokunaga, Organ-specific endoglin (CD105) expression in the angiogenesis of human cancers, Pathol Int 56 (2006), 7.
71. C. Colin, N. Baeza, C. Bartoli, F. Fina, N. Eudes, I. Nanni, P.M. Martin, L. Ouafik and D. Figarella-Branger, Identification of genes differentially expressed in glioblastoma versus pilocytic astrocytoma using suppression subtractive hybridization, Oncogene 25 (2006), 9.
72. A. Gadducci, M. Ferdeghini, A. Fanucchi, C. Annicchiarico, B. Ciampi, C. Prontera and A. Genazzani, Serum preoperative vascular endothelial growth factor (VEGF) in epithelial ovarian cancer: relationship with prognostic variables and clinical outcome, Anticancer Res 19 (1999), 5.
73. M.K. Oehler and H. Caffier, Prognostic relevance of serum vascular endothelial growth factor in ovarian cancer, Anticancer Res 20 (2000), 4.
74. B.C. Cooper, J.M. Ritchie, C.L. Broghammer, J. Coffin, J.I. Sorosky, R.E. Buller, M.J. Hendrix and A.K. Sood, Preoperative serum vascular endothelial growth factor levels: significance in ovarian cancer, Clin Cancer Res 8 (2002), 5.
75. K. Broll, G. Richter, S. Pauly, F. Hofstaedter and H. Schwarz, CD137 expression in tumor vessel walls. High correlation with malignant tumors, Am J Clin Pathol 115 (2001), 7.
76. S. Seaman, J. Stevens, M.Y. Yang, D. Logsdon, C. Graff- Cherry and B. St Croix, Genes that distinguish physiological and pathological angiogenesis, Cancer Cell 11 (2007), 16.
77. C.Y. Wu, M.S. Wu, E.P. Chiang, Y.J. Chen, C.J. Chen, N.H. Chi, Y.T. Shih, G.H. Chen and J.T. Lin, Plasma matrix metalloproteinase-9 level is better than serum matrix metalloproteinase-9 level to predict gastric cancer evolution, Clin Cancer Res 13 (2007), 15.
78. A. Scherpereel, T. Gentina, B. Grigoriu, S. Sénéchal, A. Janin, A. Tsicopoulos, F. Plénat, D. Béchard, A.B. Tonnel and P. Lassalle, Overexpression of endocan induces tumor formation, Cancer Res 63 (2003), 6.
79. D.C. DeRosa, P.J. Ryan, A. Okragly, D.R. Witcher and R.J. Benschop, Tumor-derived death receptor 6modulates dendritic cell development, Cancer Immunol Immunother 57 (2008), 11.
80. G. Yeung, J.J. Mulero, R.P. Berntsen, D.B. Loeb, R. Drmanac and J.E. Ford, Cloning of a novel epidermal growth factor repeat containing gene EGFL6: expressed in tumor and fetal tissues, Genomics 62 (1999), 4.
81. H. Terasaki, T. Saitoh, K. Shiokawa and M. Katoh, Frizzled- 10, up-regulated in primary colorectal cancer, is a positive regulator of theWNT - beta-catenin - TCF signaling pathway, Int J Mol Med 9 (2002), 6.
82. W. Cai, J. Rao, S.S. Gambhir and X. Chen, How molecular imaging is speeding up antiangiogenic drug development, Mol Cancer Ther 5 (2006), 2624-2633. (Pubitemid 44848989)
83. J.M. Provenzale, Imaging of angiogenesis: clinical techniques and novel imagingmethods, AJR AmJ Roentgenol 188 (2007), 11-23. (Pubitemid 46012485)
84. J.M. Provenzale, Imagining imaging: radiology practice in 2050, AJR Am J Roentgenol 187 (2006), 1399-1400.
85. J.C. Miller, H.H. Pien, D. Sahani, A.G. Sorensen and J.H. Thrall, Imaging angiogenesis: applications and potential for drug development, J Natl Cancer Inst 97 (2005), 172-187. (Pubitemid 40277367)
86. R.E. Pollard, T.C. Garcia, S.M. Stieger, K.W. Ferrara, A.R. Sadlowski and E.R. Wisner, Quantitative evaluation of perfusion and permeability of peripheral tumors using contrastenhanced computed tomography, Invest Radiol 39 (2004), 340-349. (Pubitemid 38669051)
87. G.R. Laking and P.M. Price, Positron emission tomographic imaging of angiogenesis and vascular function, Br J Radiol 76 Spec No 1 (2003), S50-SS59.
88. N. Lassau, S. Koscielny, M.F. Avril, A.Margulis, P. Duvillard, B.T. De, A. Roche and J. Leclere, Prognostic value of angiogenesis evaluated with high-frequency and color Doppler sonography for preoperative assessment of melanomas, AJR Am J Roentgenol 178 (2002), 1547-1551. (Pubitemid 34547848)
89. L.L. Gompels, L. Madden, N.H. Lim, J.J. Inglis, E. Mc- Connell, T.L. Vincent, D.O. Haskard and E.M. Paleolog, In vivo fluorescence imaging of E-selectin: quantitative detection of endothelial activation in a mouse model of arthritis, Arthritis Rheum 63 (2011), 107-117.
90. C. Bremer, C.H. Tung and R. Weissleder, In vivo molecular target assessment of matrix metalloproteinase inhibition, Nat Med 7 (2001), 743-748. (Pubitemid 32588033)
91. D.M. McDonald and P.L. Choyke, Imaging of angiogenesis: from microscope to clinic, Nat Med 9 (2003), 713-725. (Pubitemid 36749220)
92. C. Lu, T. Bonome, Y. Li, A.A. Kamat, L.Y. Han, R. Schmandt, R.L. Coleman, D.M. Gershenson, R.B. Jaffe, M.J. Birrer and A.K. Sood, Gene alterations identified by expression profiling in tumor-associated endothelial cells from invasive ovarian carcinoma, Cancer Res 67 (2007), 1757-1768. (Pubitemid 46383403)
93. C. Fukukawa, H. Hanaoka, S. Nagayama, T. Tsunoda, J. Toguchida, K. Endo, Y. Nakamura and T. Katagiri, Radioimmunotherapy of human synovial sarcoma using a monoclonal antibody against FZD10, Cancer Sci 99 (2008), 432-440. (Pubitemid 351228502)
94. J. Jia, J. Wang, M. Teh, W. Sun, J. Zhang, I. Kee, P.K. Chow, R.C. Liang, M.C. Chung and R. Ge, Identification of proteins differentially expressed between capillary endothelial cells of hepatocellular carcinoma and normal liver in an orthotopic rat tumor model using 2-D DIGE, Proteomics 10 (2010), 224-234.
95. M.K. Titulaer, D.A. Mustafa, I. Siccama, M. Konijnenburg, P.C. Burgers, A.C. Andeweg, P.A. Smitt, J.M. Kros and T.M. Luider, A software application for comparing large numbers of high resolution MALDI-FTICR MS spectra demonstrated by searching candidate biomarkers for glioma blood vessel formation, BMC Bioinformatics 9 (2008), 133.
96. C. Ghilardi, G. Chiorino, R. Dossi, Z. Nagy, R. Giavazzi and M. Bani, Identification of novel vascular markers through gene expression profiling of tumor-derived endothelium, BMC Genomics 9 (2008), 201.
97. B. Borgia, C. Roesli, T. Fugmann, C. Schliemann, M. Cesca, D. Neri and R. Giavazzi, A proteomic approach for the identification of vascular markers of liver metastasis, Cancer Res 70 (2010), 309-318.
98. D.A. Mustafa, P.C. Burgers, L.J. Dekker, H. Charif, M.K. Titulaer, P.A. Smitt, T.M. Luider and J.M. Kros, Identification of glioma neovascularization- related proteins by using MALDI-FTMS and nano-LC fractionation to microdissected tumor vessels,Mol Cell Proteomics 6 (2007), 1147-1157. (Pubitemid 47099226)
99. D. Mustafa, M. van der Weiden, P. Zheng, A. Nigg, T.M. Luider and J.M. Kros, Expression sites of colligin 2 in glioma blood vessels, Brain Pathol 20 (2010), 50-65.